Islet transplantation has the potential to cure diabetes. If a pancreatic transplant is successful and the body adapts well to the transplanted organ, diabetes may be fundamentally resolved. However, if the surgery fails or postoperative management is inadequate, pancreatic transplantation may not provide a permanent cure for diabetes.
As a treatment for type 1 diabetes, pancreatic transplantation can potentially eliminate dependence on exogenous insulin and achieve a cure for diabetes if the surgery is successfully completed and the transplanted pancreas functions normally by secreting insulin.
But even if the surgery is successful, the transplanted pancreas may not maintain its function permanently. Over time, the transplanted organ may experience functional decline or rejection, which can lead to the recurrence of diabetes. In addition, long-term use of immunosuppressive drugs is required to prevent organ rejection, and the use and management of these drugs are critical to the success of the surgery.
After pancreatic transplantation, long-term administration of immunosuppressive drugs is necessary to prevent organ rejection, and the use and management of these drugs are key to a successful surgery. The use of immunosuppressive drugs may cause a range of side effects, including infections, an increased risk of cancer, and other health problems. Regular blood tests and medical evaluations are therefore required to ensure the function of the transplanted organ and monitor the side effects of the immunosuppressive drugs.